Newsmaker – Bob Atwill

PERTH-BASED burns treatment-focused biomedical company Clinical Cell Culture Ltd has appointed Bob Atwill as chief executive. He replaces the company’s chief financial officer Andrew Cannon, who has been C3’s interim CEO, pending a permanent appointment.